Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Wondering which card offers the best cash back rates? Learn how to compare options and make the most of your spending.
26,992 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
PayPal sits near $42 after a tough year, sparking a lively debate on whether the stock is a bargain or a trap as Q4 r...
A troubling incident sparked conversations about safety and money. This story explores how personal risk can impact f...
A big star leaving a major project isn’t just showbiz drama. It’s a real-world reminder to guard your finances with a...
Solana’s USDC mint collides with a DeFi shutdown as Drift recovery stalls; Pyra halts onboarding and preserves withdr...
Tech stock volatility puts Anthropic's planned IPO at risk as market conditions sour for high-growth debuts. A confid...
The quantum computing sector has faced a pullback, but not every hire is a misfire. This article breaks down the rece...
Risk-off sentiment is weighing on the Nasdaq as tech names retreat. This guide explains what’s moving the stock marke...
Oil breaking the $100 mark changes the risk/return math for energy investors. This guide highlights three durable pic...
The weight loss field is heating up, with Novo Nordisk leading the GLP-1 wave and Amgen pursuing a smaller, more sele...
Quantum computing promises a new tech frontier, but today's stock prices often reflect dreams more than cash flow. Th...
This guide digs into plains (pagp) 2026 earnings, translating a complex earnings transcript into practical insights f...